Sucralose affects response to oral glucose load in obese

Sucralose affects response to oral glucose load in obese
For obese adults who do not use non-nutritive sweetener, sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

M. Yanina Pepino, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues examined the acute effects of sucralose ingestion on the metabolic response to an oral glucose load in 17 obese individuals who did not use NNS and were insulin sensitive. In a randomized crossover design study, participants underwent a five-hour modified on two occasions 10 minutes after consuming sucralose or water.

The researchers found that sucralose ingestion caused significantly greater incremental increases in peak concentrations and insulin area under the curve, as well as a greater peak rate, and caused significant decreases in insulin clearance and insulin sensitivity, compared with the control condition. For active glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, glucagon incremental area under the curve, or indices of sensitivity to the ?-cell response to glucose, there were no significant differences between the conditions.

"In conclusion, the results from our study demonstrate that sucralose affects the glycemic and hormonal responses to an oral glucose load in obese people who do not normally consume NNS," the authors write. "These findings support the notion that sucralose is not metabolically inert but has physiologic effects."

Tate & Lyle provided sucralose for the study.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bile acid sequestrant reduces glucose concentration in T2DM

date Jan 30, 2013

(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, ...

Recommended for you

Faster heart rate linked to diabetes risk

date 1 hour ago

An association between resting heart rate and diabetes suggests that heart rate measures could identify individuals with a higher future risk of diabetes, according to an international team of researchers.

EBV co-infection may boost malaria mortality in childhood

date 16 hours ago

Many people who live in sub-Saharan Africa develop a natural immunity to malaria, through repeated exposure to Plasmodium parasites. Even so, the disease kills close to half a million children per year, according ...

Three important things you didn't know about diabetes

date 21 hours ago

When we think of diabetes, we tend to think of rich people with poor lifestyles. A chronic disease linked with obesity, heart disease and worse outcomes for some infectious diseases, diabetes tends to be ...

Changes observed in HbA1c during ramadan

date May 20, 2015

(HealthDay)—For patients with type 2 diabetes, during Ramadan, the greatest change among metabolic parameters is seen for glycemia, according to a study published online May 13 in the Journal of Diabetes In ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.